Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

The sphingosine-1-phospate receptor modulator fingolimod aggravates murine epidermolysis bullosa acquisita.

Thieme M, Bieber K, Sezin T, Wannick M, Gupta Y, Kalies K, Ludwig RJ, Mousavi S, Zillikens D, Sadik CD.

J Invest Dermatol. 2019 Jun 6. pii: S0022-202X(19)31630-6. doi: 10.1016/j.jid.2019.03.1159. [Epub ahead of print] No abstract available.

PMID:
31176709
2.

Current Clinical Trials in Pemphigus and Pemphigoid.

Izumi K, Bieber K, Ludwig RJ.

Front Immunol. 2019 May 3;10:978. doi: 10.3389/fimmu.2019.00978. eCollection 2019. Review.

3.

Darwin's Other Dilemmas and the Theoretical Roots of Emotional Connection.

Ludwig RJ, Welch MG.

Front Psychol. 2019 Apr 12;10:683. doi: 10.3389/fpsyg.2019.00683. eCollection 2019. Review.

4.

Type VII collagen IgE autoantibodies in epidermolysis bullosa acquisita: more common than suspected.

Ludwig RJ.

Br J Dermatol. 2019 May;180(5):981-983. doi: 10.1111/bjd.17770. No abstract available.

PMID:
31025734
5.

Editorial: Skin Blistering Diseases.

Has C, Amber KT, Murrell DF, Musette P, Ludwig RJ.

Front Med (Lausanne). 2019 Apr 2;6:60. doi: 10.3389/fmed.2019.00060. eCollection 2019. No abstract available.

6.

Proinflammatory Cytokine Gene Polymorphisms in Bullous Pemphigoid.

Tabatabaei-Panah PS, Moravvej H, Sadaf Z, Babaei H, Geranmayeh M, Hajmanouchehri S, Karimi A, Sajjadi F, Arghand F, Ludwig RJ, Witte M, Akbarzadeh R.

Front Immunol. 2019 Mar 29;10:636. doi: 10.3389/fimmu.2019.00636. eCollection 2019.

7.

Editorial: Autoantibodies.

Holmdahl R, Nimmerjahn F, Ludwig RJ.

Front Immunol. 2019 Apr 2;10:484. doi: 10.3389/fimmu.2019.00484. eCollection 2019. No abstract available.

8.

Bullous pemphigoid: more than one disease?

Ludwig RJ.

J Eur Acad Dermatol Venereol. 2019 Mar;33(3):459-460. doi: 10.1111/jdv.15445. No abstract available.

PMID:
30891848
9.

Autonomic regulation of preterm infants is enhanced by Family Nurture Intervention.

Porges SW, Davila MI, Lewis GF, Kolacz J, Okonmah-Obazee S, Hane AA, Kwon KY, Ludwig RJ, Myers MM, Welch MG.

Dev Psychobiol. 2019 Mar 13. doi: 10.1002/dev.21841. [Epub ahead of print]

PMID:
30868570
10.

Translational Use of a Standardized Full Human Skin Organ Culture Model in Autoimmune Blistering Diseases.

Burmester IAK, Emtenani S, Johns JG, Ludwig RJ, Hammers CM, Hundt JE.

Curr Protoc Pharmacol. 2019 Mar 8:e56. doi: 10.1002/cpph.56. [Epub ahead of print]

PMID:
30848563
11.

Drug Discovery for Pemphigoid Diseases.

Kasprick A, Bieber K, Ludwig RJ.

Curr Protoc Pharmacol. 2019 Mar;84(1):e55. doi: 10.1002/cpph.55. Epub 2019 Feb 20.

PMID:
30786171
12.

Epidermolysis Bullosa Acquisita: The 2019 Update.

Koga H, Prost-Squarcioni C, Iwata H, Jonkman MF, Ludwig RJ, Bieber K.

Front Med (Lausanne). 2019 Jan 10;5:362. doi: 10.3389/fmed.2018.00362. eCollection 2018. Review.

13.

Perinatal antibiotics alter preterm infant EEG and neurobehavior in the Family Nurture Intervention trial.

Firestein MR, Myers MM, Austin J, Stark RI, Barone JL, Ludwig RJ, Welch MG.

Dev Psychobiol. 2019 Jan 22. doi: 10.1002/dev.21820. [Epub ahead of print]

PMID:
30671945
14.

Assessing Cellular Stress and Inflammation in Discrete Oxytocin-secreting Brain Nuclei in the Neonatal Rat Before and After First Colostrum Feeding.

Klein BY, Tamir H, Anwar M, Ludwig RJ, Kaidbey JH, Glickstein SB, Welch MG.

J Vis Exp. 2018 Nov 14;(141). doi: 10.3791/58341.

PMID:
30507911
15.

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference.

Lee J, Werth VP, Hall RP 3rd, Eming R, Fairley JA, Fajgenbaum DC, Harman KE, Jonkman MF, Korman NJ, Ludwig RJ, Murrell DF, Musette P, Naik HB, Sadik CD, Yamagami J, Yale ML, Payne AS.

Front Med (Lausanne). 2018 Nov 8;5:306. doi: 10.3389/fmed.2018.00306. eCollection 2018.

16.

Family nurture intervention for preterm infants facilitates positive mother-infant face-to-face engagement at 4 months.

Beebe B, Myers MM, Lee SH, Lange A, Ewing J, Rubinchik N, Andrews H, Austin J, Hane A, Margolis AE, Hofer M, Ludwig RJ, Welch MG.

Dev Psychol. 2018 Nov;54(11):2016-2031. doi: 10.1037/dev0000557. Epub 2018 Oct 4.

PMID:
30284883
17.

IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid.

Chakievska L, Holtsche MM, Künstner A, Goletz S, Petersen BS, Thaci D, Ibrahim SM, Ludwig RJ, Franke A, Sadik CD, Zillikens D, Hölscher C, Busch H, Schmidt E.

J Autoimmun. 2019 Jan;96:104-112. doi: 10.1016/j.jaut.2018.09.003. Epub 2018 Sep 13.

18.

Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients.

Iwata H, Vorobyev A, Koga H, Recke A, Zillikens D, Prost-Squarcioni C, Ishii N, Hashimoto T, Ludwig RJ.

Orphanet J Rare Dis. 2018 Sep 4;13(1):153. doi: 10.1186/s13023-018-0896-1.

19.

The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations.

Kridin K, Ludwig RJ.

Front Med (Lausanne). 2018 Aug 20;5:220. doi: 10.3389/fmed.2018.00220. eCollection 2018. Review.

20.

Corrigendum to "Colostrum oxytocin modulates cellular stress response, inflammation, and autophagy markers in newborn rat gut villi" [Biochem. Biophys. Res. Commun. 487 (2017) 47-53].

Klein BY, Tamir H, Ludwig RJ, Glickstein SB, Welch MG.

Biochem Biophys Res Commun. 2018 Sep 5;503(2):1174. doi: 10.1016/j.bbrc.2018.07.085. Epub 2018 Jul 24. No abstract available.

PMID:
30054045
21.

Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita.

Koga H, Kasprick A, López R, Aulí M, Pont M, Godessart N, Zillikens D, Bieber K, Ludwig RJ, Balagué C.

Front Immunol. 2018 Jul 12;9:1558. doi: 10.3389/fimmu.2018.01558. eCollection 2018.

22.

Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata.

Moravvej H, Tabatabaei-Panah PS, Abgoon R, Khaksar L, Sokhandan M, Tarshaei S, Ghaderian SMH, Ludwig RJ, Akbarzadeh R.

Immunol Invest. 2018 Oct;47(7):666-679. doi: 10.1080/08820139.2018.1480032. Epub 2018 Jul 6.

PMID:
29979892
23.

Induction of Hypergammaglobulinemia and Autoantibodies by Salmonella Infection in MyD88-Deficient Mice.

Issac JM, Mohamed YA, Bashir GH, Al-Sbiei A, Conca W, Khan TA, Iqbal A, Riemekasten G, Bieber K, Ludwig RJ, Cabral-Marques O, Fernandez-Cabezudo MJ, Al-Ramadi BK.

Front Immunol. 2018 Jun 20;9:1384. doi: 10.3389/fimmu.2018.01384. eCollection 2018.

24.

The Welch Emotional Connection Screen: validation of a brief mother-infant relational health screen.

Hane AA, LaCoursiere JN, Mitsuyama M, Wieman S, Ludwig RJ, Kwon KY, V Browne J, Austin J, M Myers M, Welch MG.

Acta Paediatr. 2019 Apr;108(4):615-625. doi: 10.1111/apa.14483. Epub 2018 Aug 13.

PMID:
29959878
25.

TNF-α -308G/A gene polymorphism in bullous pemphigoid and alopecia areata.

Moravvej H, Tabatabaei-Panah PS, Ebrahimi E, Esmaeili N, Ghaderian SMH, Ludwig RJ, Akbarzadeh R.

Hum Antibodies. 2018;26(4):201-207. doi: 10.3233/HAB-180339.

PMID:
29843231
26.

Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease.

Haeberle S, Wei X, Bieber K, Goletz S, Ludwig RJ, Schmidt E, Enk AH, Hadaschik EN.

J Allergy Clin Immunol. 2018 Dec;142(6):1831-1842.e7. doi: 10.1016/j.jaci.2018.04.006. Epub 2018 Apr 26.

PMID:
29704595
27.

Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparins.

Schindewolf M, Paulik M, Kroll H, Kaufmann R, Wolter M, Boehncke WH, Lindhoff-Last E, Recke A, Ludwig RJ.

Clin Exp Allergy. 2018 Aug;48(8):1016-1024. doi: 10.1111/cea.13159. Epub 2018 Jun 5.

PMID:
29683226
28.

Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.

Recke A, Regensburger AK, Weigold F, Müller A, Heidecke H, Marschner G, Hammers CM, Ludwig RJ, Riemekasten G.

Front Immunol. 2018 Mar 22;9:428. doi: 10.3389/fimmu.2018.00428. eCollection 2018.

29.

Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.

Mihai S, Hirose M, Wang Y, Thurman JM, Holers VM, Morgan BP, Köhl J, Zillikens D, Ludwig RJ, Nimmerjahn F.

Front Immunol. 2018 Mar 16;9:535. doi: 10.3389/fimmu.2018.00535. eCollection 2018.

30.

Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.

Karsten CM, Beckmann T, Holtsche MM, Tillmann J, Tofern S, Schulze FS, Heppe EN, Ludwig RJ, Zillikens D, König IR, Köhl J, Schmidt E.

Front Immunol. 2018 Mar 15;9:488. doi: 10.3389/fimmu.2018.00488. eCollection 2018.

31.

Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis.

Kasperkiewicz M, Schmidt E, Ludwig RJ, Zillikens D.

Front Immunol. 2018 Feb 19;9:254. doi: 10.3389/fimmu.2018.00254. eCollection 2018. Review.

32.

Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita.

Samavedam UK, Mitschker N, Kasprick A, Bieber K, Schmidt E, Laskay T, Recke A, Goletz S, Vidarsson G, Schulze FS, Armbrust M, Schulze Dieckhoff K, Pas HH, Jonkman MF, Kalies K, Zillikens D, Gupta Y, Ibrahim SM, Ludwig RJ.

Front Immunol. 2018 Feb 15;9:249. doi: 10.3389/fimmu.2018.00249. eCollection 2018.

33.

IgE-Selective Immunoadsorption for Severe Atopic Dermatitis.

Kasperkiewicz M, Mook SC, Knuth-Rehr D, Vorobyev A, Ludwig RJ, Zillikens D, Muck P, Schmidt E.

Front Med (Lausanne). 2018 Feb 12;5:27. doi: 10.3389/fmed.2018.00027. eCollection 2018.

34.

Gene Expression Analysis Reveals Novel Shared Gene Signatures and Candidate Molecular Mechanisms between Pemphigus and Systemic Lupus Erythematosus in CD4+ T Cells.

Sezin T, Vorobyev A, Sadik CD, Zillikens D, Gupta Y, Ludwig RJ.

Front Immunol. 2018 Jan 17;8:1992. doi: 10.3389/fimmu.2017.01992. eCollection 2017.

35.

Calming Cycle Theory and the Co-Regulation of Oxytocin.

Welch MG, Ludwig RJ.

Psychodyn Psychiatry. 2017 Winter;45(4):519-540. doi: 10.1521/pdps.2017.45.4.519.

PMID:
29244620
36.

Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases.

Bieber K, Sun S, Witte M, Kasprick A, Beltsiou F, Behnen M, Laskay T, Schulze FS, Pipi E, Reichhelm N, Pagel R, Zillikens D, Schmidt E, Sparwasser T, Kalies K, Ludwig RJ.

Front Immunol. 2017 Nov 24;8:1628. doi: 10.3389/fimmu.2017.01628. eCollection 2017.

37.

New insights into pemphigoid diseases.

Antonicelli F, Ludwig RJ.

Exp Dermatol. 2017 Dec;26(12):1151-1153. doi: 10.1111/exd.13469. No abstract available.

PMID:
29159879
38.

Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita.

Tukaj S, Bieber K, Witte M, Ghorbanalipoor S, Schmidt E, Zillikens D, Ludwig RJ, Kasperkiewicz M.

J Invest Dermatol. 2018 Feb;138(2):301-309. doi: 10.1016/j.jid.2017.09.009. Epub 2017 Sep 20.

39.

Nanoparticles prepared from porcine cells support the healing of cutaneous inflammation in mice and wound re-epithelialization in human skin.

Kunz N, Hauenschild E, Maass S, Kalies KU, Klinger M, Barra M, Hecht L, Helbig F, Soellner S, Caldwell CC, Ludwig RJ, Westermann J, Kalies K.

Exp Dermatol. 2017 Dec;26(12):1199-1206. doi: 10.1111/exd.13450. Epub 2017 Nov 7.

PMID:
28940860
40.

The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies.

Kasprick A, Holtsche MM, Rose EL, Hussain S, Schmidt E, Petersen F, Panicker S, Ludwig RJ.

J Invest Dermatol. 2018 Feb;138(2):458-461. doi: 10.1016/j.jid.2017.08.030. Epub 2017 Sep 9. No abstract available.

41.

Evidence for a contributory role of a xenogeneic immune response in experimental epidermolysis bullosa acquisita.

Niebuhr M, Kasperkiewicz M, Maass S, Hauenschild E, Bieber K, Ludwig RJ, Westermann J, Kalies K.

Exp Dermatol. 2017 Dec;26(12):1207-1213. doi: 10.1111/exd.13439.

PMID:
28887841
42.

Family nurture intervention in preterm infants increases early development of cortical activity and independence of regional power trajectories.

Welch MG, Stark RI, Grieve PG, Ludwig RJ, Isler JR, Barone JL, Myers MM.

Acta Paediatr. 2017 Dec;106(12):1952-1960. doi: 10.1111/apa.14050. Epub 2017 Sep 25.

PMID:
28850710
43.

CCL3/MIP1α represents a biomarker but not a mandatory cytokine for disease development in experimental epidermolysis bullosa acquisita.

Kasperkiewicz M, Kalies K, Pagel R, Bieber K, Zillikens D, Ludwig RJ.

J Dermatol Sci. 2017 Nov;88(2):248-250. doi: 10.1016/j.jdermsci.2017.06.019. Epub 2017 Jun 30. No abstract available.

PMID:
28711238
44.

Mechanisms of Autoantibody-Induced Pathology.

Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan SM, Komorowski L, Luo J, Cabral-Marques O, Hammers CM, Lindstrom JM, Lamprecht P, Fischer A, Riemekasten G, Tersteeg C, Sondermann P, Rapoport B, Wandinger KP, Probst C, El Beidaq A, Schmidt E, Verkman A, Manz RA, Nimmerjahn F.

Front Immunol. 2017 May 31;8:603. doi: 10.3389/fimmu.2017.00603. eCollection 2017. Review.

45.

Increased TREM-1 expression in inflamed skin has no functional impact on the pathogenesis of cutaneous disorders.

Dräger S, Kalies K, Sidronio TB, Witte M, Ludwig RJ, Bieber K.

J Dermatol Sci. 2017 Oct;88(1):152-155. doi: 10.1016/j.jdermsci.2017.05.016. Epub 2017 May 30. No abstract available.

PMID:
28610717
46.

Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid.

Bieber K, Ernst AL, Tukaj S, Holtsche MM, Schmidt E, Zillikens D, Ludwig RJ, Kasperkiewicz M.

Exp Dermatol. 2017 Dec;26(12):1248-1252. doi: 10.1111/exd.13382. Epub 2017 Aug 15.

PMID:
28500685
47.

Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016.

Schmidt E, Spindler V, Eming R, Amagai M, Antonicelli F, Baines JF, Belheouane M, Bernard P, Borradori L, Caproni M, Di Zenzo G, Grando S, Harman K, Jonkman MF, Koga H, Ludwig RJ, Kowalczyk AP, Müller EJ, Nishie W, Pas H, Payne AS, Sadik CD, Seppänen A, Setterfield J, Shimizu H, Sinha AA, Sprecher E, Sticherling M, Ujiie H, Zillikens D, Hertl M, Waschke J.

J Invest Dermatol. 2017 Jun;137(6):1199-1203. doi: 10.1016/j.jid.2017.01.028. Epub 2017 Apr 5. Review.

48.

Colostrum oxytocin modulates cellular stress response, inflammation, and autophagy markers in newborn rat gut villi.

Klein BY, Tamir H, Ludwig RJ, Glickstein SB, Welch MG, Anwar M.

Biochem Biophys Res Commun. 2017 May 20;487(1):47-53. doi: 10.1016/j.bbrc.2017.04.011. Epub 2017 Apr 5. Erratum in: Biochem Biophys Res Commun. 2018 Sep 5;503(2):1174.

PMID:
28389244
49.

Nadroparin carries a potentially high risk of inducing cutaneous delayed-type hypersensitivity responses.

Schindewolf M, Recke A, Zillikens D, Lindhoff-Last E, Ludwig RJ.

Contact Dermatitis. 2017 Jul;77(1):35-41. doi: 10.1111/cod.12764. Epub 2017 Mar 14.

PMID:
28294347
50.

Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisita.

Ludwig RJ.

Exp Dermatol. 2017 Dec;26(12):1179-1186. doi: 10.1111/exd.13335. Epub 2017 May 9. Review.

PMID:
28266741

Supplemental Content

Loading ...
Support Center